Hsv 1 and 2 Gowey Protocol Versus Placebo

Phase II Clinical Trial of Versabase/Sarracenia Purpurea Versus Placebo

This study will compare efficacy of versabase gel with 20% sarracenia purpurea versus placebo applied every 3-4 hours to herpes lesions.

Patients screened for hsv one or two. Patients with herpes given a 1/8 oz of gel. Researcher does not know which is active and which is placebo (placebo is actually just versabase gel). Patent applies gel to lesions every 3-4 hours. Returns to clinic on days 3, 5, and 14 for evaluation. Up to 50 patients may be enrolled.

Inclusion Criteria:

- Hsv 1&2

Exclusion Criteria:

• No active lesions